2,683
Views
7
CrossRef citations to date
0
Altmetric
Short Communication

Comparison of blood carbonic anhydrase activity of athletes performing interval and continuous running exercise at high altitude

, , , , , , , & ORCID Icon show all
Pages 218-223 | Received 17 Oct 2018, Accepted 05 Nov 2018, Published online: 06 Dec 2018

References

  • (a) Tripp BC, Smith K, Ferry JG. Carbonic anhydrase: new insights for an ancient enzyme. J Biol Chem 2001;276:48615–8. (b) Borras J, Scozzafava A, Menabuoni L. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? Bioorg Med Chem 1999;7:2397–406. (c) Supuran CT. Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? J Enzyme Inhib Med Chem 2018; 33:485–95. (d) Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat 2018;28:709–12. (e) Supuran CT. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases. Expert Opin Ther Pat 2018;28:713–21. (f) Nocentini A, Supuran CT. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). Expert Opin Ther Pat 2018;28:729–40. (g) Supuran CT, Capasso C. Biomedical applications of prokaryotic carbonic anhydrases. Expert Opin Ther Pat 2018; 28:745–54.
  • (a) Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81. (b) Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60. (c) Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68. (d) Abbate F, Winum JY, Potter BV, et al. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. Bioorg Med Chem Lett 2004;14:231–4. (e) Capasso C, Supuran CT. An overview of the alpha-, beta-and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2015;30:325–32. (f) Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88. (g) Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
  • (a) Hilvo M, Tolvanen M, Clark A, et al. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem J 2005;392:83–92. (b) Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat. Rev. Drug Discov 2011; 10:767–77. (c) Supuran CT, Vullo D, Manole G, et al. Designing of novel carbonic anhydrase inhibitors and activators. Curr Med Chem Cardiovasc Hematol Agents 2004;2:49–68.
  • Puscas I, Puscas C, Coltau M, et al. The serum of carcinoma patients powerfully activates carbonic anhydrase II. Exp Oncol 2000;22:162–4.
  • Heyward VH. Designing cardiorespiratory exercise programs. Advanced fitness assessment and exercise prescription. 5th ed. Champaign, Illinois: Human Kinetics; 2006.
  • Kenney WL, Wilmore JH, Costill DL. Principles of exercise training. Physiology of sport and exercise. 5th ed. Champaign, Illinois: Human Kinetics; 2011.
  • Wilmore JH. Physical athletic training and physical fitness: principles and practices of the conditioning process. Baltimore: Allyn and Bacon 1977; ISBN 0-205-05630-X.
  • Heyward VH. Designing cardiorespiratory exercise programs. Advanced fitness assessment and exercise prescription. 5th ed. Champaign, Illinois: Human Kinetics; 2006.
  • Tan S, Wang X, Wang J. Effects of supervised exercise training at the intensity of maximal fat oxidation in overweight young women. J Exercise Sci Fitness 2012;10:64–9.
  • Achten J, Jeukendrup AE. The effect of pre-exercise carbohydrate feedings on the intensity that elicits maximal fat oxidation. J Sports Sci 2003;21:1017–24.
  • Bogdanis GC, Vangelakoudi A, Maridaki M. Peak fat oxidation rate during walking in sedentary overweight men and women. J Sports Sci Med 2008;7:525–31.
  • (a) Demirdag R, Comakli V, Senturk M, et al. Characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity. Bioorg Med Chem 2013;2:1522–5. (b) Turkoglu EA, Senturk M, Supuran CT, et al. Carbonic anhydrase inhibitory properties of some uracil derivatives. J Enzym Inhib Med Chem 2017;32:74–7. (c) Şentürk M, Gülçin İ, Beydemir Ş, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011;77:494–9. (d) Fabrizi F, Mincione F, Somma T, et al. A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology. J Enzyme Inhib Med Chem 2012; 27:138–47. (e) Krall N, Pretto F, Decurtins W, et al. A small‐molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. Angew Chem Int Ed Engl 2014;53:4231–5. (f) Rehman SU, Chohan ZH, Gulnaz F, Supuran CT. In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes. J Enzyme Inhib Med Chem 2005;20:333–40. (g) Clare BW, Supuran CT. Carbonic anhydrase activators. 3: Structure‐activity correlations for a series of isozyme II activators. J Pharm Sci 1994;83:768–73.
  • (a) Abdel-Aziz AA-M, El-Azab AS, Ekinci D, et al. Investigation of arenesulfonyl-2-imidazolidinones as potent carbonic anhydrase inhibitors. J Enzym Inhib Med Chem 2015;30:81–4. (b) Gulçin İ, Abbasova M, Taslimi P, et al. Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2017; 32:1174–82. (c) Mocan A, Zengin G, Simirgiotis M, et al. Functional constituents of wild and cultivated Goji (L. barbarum L.) leaves: phytochemical characterization, biological profile, and computational studies. J Enzyme Inhib Med Chem 2017;32:153–68.
  • (a) Ekinci D, Cavdar H, Talaz O, et al. NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II. Bioorg Med Chem 2010;18:3559–63. (b) Dubois L, Peeters S, Lieuwes NG, et al. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol 2011; 99:424–31. (c) Chohan ZH, Munawar A, Supuran CT. Transition metal ion complexes of Schiff-bases. Synthesis, characterization and antibacterial properties. Met Based Drugs 2001; 8: 137–43. (d) Zimmerman SA, Ferry JG, Supuran CT. Inhibition of the archaeal β-class (Cab) and γ-class (Cam) carbonic anhydrases. Curr Top Med Chem 2007; 7:901–8.
  • Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9.
  • Isik S, Vullo D, Durdagi S, et al. Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives. Bioorg Med Chem Lett 2015;25:5636–41.
  • Ekinci D, Senturk M, Senturk E. Purification and characterization of carbonic anhydrase enzyme from bovine heart tissue and investigation of inhibition effects of some sulphonamide derivative drugs. Acta Physıol 2015;215:7353–8.
  • Bradford MM. A rapid and sensitive method for the quantition of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–51.
  • Kowalchuk JM, Heigenhauser GJ, Sutton JR, Jones NL. effect of acetazolamide on gas exchange and acid-base control after maximal exercise. J Appl Physiol 1992;72:278–87.
  • Brooks GA. Anaerobic threshold: review of the concepts and directions for future research. Med Sci Sports Exerc 1985;17:22–31.
  • Davis JA. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 1985;17:6–18.
  • Scheuermann BW, Kowalchuk JM, Paterson DH, Cunningham DA. Carbonic anhydrase inhibition delays plasma lactate appearance with no effect on ventilatory threshold. J Appl Physiol 2000;88:713–21.
  • Posch AM, Dandorf S, Hile DC. The effects of acetazolamide on exercise performance at sea level and in hypoxic environments: a review. Wilderness Environ Med 2018;S1080-6032: 30118–2. doi: 10.1016/j.wem.2018.06.011.
  • Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 2000;80:681–715.
  • Wilber RL. Current trends in altitude training. Sports Med 2001;32:249–65.
  • (a) Tas M, Senturk E, Senturk M. Carbonic anhydrase activity as a new parameter in exercise physiology. Acta Physiol 2015;215:82. (b) Ferraroni M, Gaspari R, Scozzafava A, et al. Dioxygen, an unexpected carbonic anhydrase ligand. J Enzyme Inhib Med Chem 2018; 33:999–1005.
  • (a) Senturk E, Senturk M, Ekinci D. Comparison of inhibition effects of some anions on carbonic anhydrase isoenzymes from mammalian kidney tissues. Acta Physiol 2015;215:99. (b) Bouchouit M, Bouacida S, Zouchoune B, et al. Synthesis, X-ray structure, in silico calculation, and carbonic anhydrase inhibitory properties of benzylimidazole metal complexes. J Enzyme Inhib Med Chem 2018; 33:1150–9.
  • (a) Yaseen R, Ekinci D, Senturk M, et al. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2016;26:1337–41. (b) Akocak S, Lolak N, Bua S, Supuran CT. Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors. J Enzyme Inhib Med Chem 2018;33:1575–80. (c) Güzel-Akdemir Ö, Angeli A, Demir K, et al. Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors. J Enzyme Inhib Med Chem 2018; 33:1299–308.